Abstract:Background Glioma represents the predominant primary malignant brain tumor. For several years, molecular profiling has been instrumental in the management and therapeutic stratification of glioma, providing a deeper understanding of its biological complexity. Accumulating evidence unveils the putative involvement of zinc finger proteins (ZNFs) in cancer. This study aimed to elucidate the role and significance of ZNF207 in glioma. Methods Utilizing online data such as The Cancer Genome Atlas (TCGA), the Chinese Glioma Genome Atlas (CGGA), the Genotype‐Tissue Expression (GTEx) project, the Clinical Proteomic Tumor Analysis Consortium (CPTAC), and the Human Protein Atlas (HPA) databases, in conjunction with bioinformatics methodologies including GO, KEGG, GSEA, CIBERSORT immune cell infiltration estimation, and protein–protein interaction (PPI) analysis, enabled a comprehensive exploration of ZNF207's involvement in gliomagenesis. Immunohistochemistry and RT‐PCR techniques were employed to validate the expression level of ZNF207 in glioma samples. Subsequently, the biological effects of ZNF207 on glioma cells were explored through in vitro assays. Results Our results demonstrate elevated expression of ZNF207 in gliomas, correlating with unfavorable patient outcomes. Stratification analyses were used to delineate the prognostic efficacy of ZNF207 in glioma with different clinicopathological characteristics. Immunocorrelation analysis revealed a significant association between ZNF207 expression and the infiltration levels of T helper cells, macrophages, and natural killer (NK) cells. Utilizing ZNF207 expression and clinical features, we constructed an OS prediction model and displayed well discrimination with a C‐index of 0.861. Moreover, the strategic silencing of ZNF207 attenuated glioma cell advancement, evidenced by diminished cellular proliferation, weakened cell tumorigenesis, augmented apoptotic activity, and curtailed migratory capacity alongside the inhibition of the epithelial‐mesenchymal transition (EMT) pathway. Conclusions ZNF207 may identify as a prospective biomarker and therapeutic candidate for glioma prevention, providing valuable insights into understanding glioma pathogenesis and treatment strategies.

Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells

Function Study of Epha2 Gene in the Cell Apoptosis, Growth, Migration and Invasion of Glioma Cell Line U251

Inhibition Of Eef-2 Kinase Sensitizes Human Glioma Cells To Trail And Down-Regulates Bcl-Xl Expression

Expression of Dedifferentiation Markers and Multilineage Markers in U251 Glioblastoma Cells with Silenced EGFR and FGFR Genes.

Inhibition Of Elongation Factor-2 Kinase Augments The Antitumor Activity Of Temozolomide Against Glioma

Eukaryotic Extension Factor 2 Kinase may Affect the Occurrence and Development of Glioblastoma Through Immune Cell Infiltration

eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206

Transcriptional Upregulation of Microtubule-Associated Protein 2 is Involved in the Protein Kinase A-Induced Decrease in the Invasiveness of Glioma Cells

AEG-1/MTDH-activated Autophagy Enhances Human Malignant Glioma Susceptibility to TGF-β1-triggered Epithelial-Mesenchymal Transition

IKBKE promotes the ZEB2-mediated EMT process by phosphorylating HMGA1a in glioblastoma

Knockdown of Angiopoietin-Like Protein 2 Inhibits Proliferation and Invasion in Glioma Cells Via Suppressing the ERK/MAPK Signaling Pathway.

Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF-A pathway

ERK and PI3K Signaling Cascades Induce Nrf2 Activation and Regulate Cell Viability Partly Through Nrf2 in Human Glioblastoma Cells.

Eef2k As an Important Kinase Associated with Cancer Survival and Prognosis

Astrocyte elevated gene-1 serves as a target of miR542 to promote glioblastoma proliferation and invasion

Function of a complex of p-Y42 RhoA GTPase and pyruvate kinase M2 in EGF signaling pathway in glioma cells

Epidermal Growth Factor (Egf)-Enhanced Vascular Cell Adhesion Molecule-1 (Vcam-1) Expression Promotes Macrophage and Glioblastoma Cell Interaction and Tumor Cell Invasion

Migfilin Promotes Migration and Invasion in Glioma by Driving EGFR and MMP-2 Signalings: A Positive Feedback Loop Regulation.

Zinc finger Protein207 orchestrates glioma migration through regulation of epithelial‐mesenchymal transition

Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future

EphB3 receptor suppressor invasion, migration and proliferation in glioma by inhibiting EGFR-PI3K/AKT signaling pathway